Back
PROCEPT BioRobotics 10K Form
Buy
65
PRCT
PROCEPT BioRobotics
Last Price:
95.42
Seasonality Move:
-5.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PRCT News And Ratings
See the #1 stock for the next 7 days that we like better than PRCT
PRCT Financial Statistics
Sales & Book Value
Annual Sales: | $136.19M |
---|---|
Cash Flow: | $-19.05M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.63 |
Price / Book: | 21.41 |
Profitability
EPS (TTM): | -1.95000 |
---|---|
Net Income (TTM): | $-100.06M |
Gross Margin: | $71.05M |
Return on Equity: | -37.42% |
Return on Assets: | -25.56% |
PROCEPT BioRobotics Earnings Forecast
Key PROCEPT BioRobotics Financial Ratios
- The Gross Profit Margin over the past 5 years for PRCT is 52.17%.
- The Selling, General & Administrative Expenses for PRCT have been equal to 96.76% of Gross Profit Margin.
- The Research & Development expenses have been 35.57% of Revenue.
- The Interest Expense is -3.77% of Operating Income.
- The Net Earning history of PRCT is -77.76% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 1 years.
PROCEPT BioRobotics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | PRCT |
Website: | procept-biorobotics.com |
Debt
Debt-to-Equity Ratio: | 0.21 |
---|---|
Current Ratio: | 6.02 |
Quick Ratio: | 4.95 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
PRCT Technical Analysis vs Fundamental Analysis
Buy
65
PROCEPT BioRobotics (PRCT)
is a Buy
Is PROCEPT BioRobotics a Buy or a Sell?
-
PROCEPT BioRobotics stock is rated a Buy
The current PROCEPT BioRobotics [PRCT] share price is $95.46. The Score for PRCT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.